Jiangxi Synergy Pharmaceutical Co Ltd (300636) — Capital Reinvestment Ratio
Jiangxi Synergy Pharmaceutical Co Ltd (300636) has a Capital Reinvestment Ratio of 1.49x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥65.40 Million) in capital expenditures (CN¥97.21 Million). See cash generation quality of Jiangxi Synergy Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangxi Synergy Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Jiangxi Synergy Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Jiangxi Synergy Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Jiangxi Synergy Pharmaceutical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see 300636 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.44x | CN¥202.07 Million | CN¥291.24 Million | ▲ +201.1% |
| 2024 | 0.48x | CN¥285.19 Million | CN¥136.49 Million | ▼ -63.5% |
| 2023 | 1.31x | CN¥163.75 Million | CN¥214.65 Million | ▼ -17.5% |
| 2022 | 1.59x | CN¥196.00 Million | CN¥311.49 Million | ▼ -50.8% |
| 2021 | 3.23x | CN¥131.34 Million | CN¥424.67 Million | ▲ +12.6% |
| 2020 | 2.87x | CN¥80.07 Million | CN¥229.99 Million | ▼ -11.2% |
| 2018 | 3.23x | CN¥74.93 Million | CN¥242.37 Million | ▼ -4.3% |
| 2017 | 3.38x | CN¥34.05 Million | CN¥115.11 Million | ▲ +607.5% |
| 2016 | 0.48x | CN¥60.45 Million | CN¥28.88 Million | ▼ -51.7% |
| 2015 | 0.99x | CN¥79.42 Million | CN¥78.53 Million | ▲ +104.2% |
| 2014 | 0.48x | CN¥64.50 Million | CN¥31.24 Million | ▼ -79.6% |
| 2013 | 2.37x | CN¥14.42 Million | CN¥34.20 Million | — |